These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 382915)

  • 1. Renal function and the pharmacokinetics of neostigmine in anesthetized man.
    Cronnelly R; Stanski DR; Miller RD; Sheiner LB; Sohn YJ
    Anesthesiology; 1979 Sep; 51(3):222-6. PubMed ID: 382915
    [No Abstract]   [Full Text] [Related]  

  • 2. TUBOCURARINE ADMINISTRATION BASED UPON ITS DISAPPEARANCE AND ACCUMULATION CURVES IN ANAESTHETIZED MAN.
    RYAN AR
    Br J Anaesth; 1964 May; 36():287-94. PubMed ID: 14168468
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacokinetics and pharmacodynamics of d-tubocurarine during nitrous oxide-narcotic and halothane anesthesia in man.
    Stanski DR; Ham J; Miller RD; Sheiner LB
    Anesthesiology; 1979 Sep; 51(3):235-41. PubMed ID: 475025
    [No Abstract]   [Full Text] [Related]  

  • 4. DIALLYL TOXIFERINE.
    HUNTER AR
    Br J Anaesth; 1964 Aug; 36():466-70. PubMed ID: 14202198
    [No Abstract]   [Full Text] [Related]  

  • 5. [Anesthesia in homologous kidney transplantation].
    Eckart J; Perazic M; Nagel R
    Anaesthesist; 1966 Mar; 15(3):93-6. PubMed ID: 4863536
    [No Abstract]   [Full Text] [Related]  

  • 6. Hazards of gallamine administration in patients with renal failure.
    McLaughlin AP; Altwein JE; Kessler WO; Gittes RF
    J Urol; 1972 Oct; 108(4):515-7. PubMed ID: 4651336
    [No Abstract]   [Full Text] [Related]  

  • 7. The influence of renal failure on the pharmacokinetics and duration of action of pipecuronium bromide in patients anesthetized with halothane and nitrous oxide.
    Caldwell JE; Canfell PC; Castagnoli KP; Lynam DP; Fahey MR; Fisher DM; Miller RD
    Anesthesiology; 1989 Jan; 70(1):7-12. PubMed ID: 2536254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antagonism of d-tubocurarine- and pancuronium-induced neuromuscular blockades by pyridostigmine in man.
    Fogdall RP; Miller RD
    Anesthesiology; 1973 Nov; 39(5):504-9. PubMed ID: 4355635
    [No Abstract]   [Full Text] [Related]  

  • 9. The pharmacokinetics of d-tubocurarine in man with and without renal failure.
    Miller RD; Matteo RS; Benet LZ; Sohn YJ
    J Pharmacol Exp Ther; 1977 Jul; 202(1):1-7. PubMed ID: 195035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of administration of atropine and neostigmine in man.
    Ovassapian A
    Anesth Analg; 1969; 48(2):219-23. PubMed ID: 5813068
    [No Abstract]   [Full Text] [Related]  

  • 11. Anaesthesia in irreversible renal failure.
    Hewitt PB
    Guys Hosp Rep; 1970; 119(3):195-208. PubMed ID: 4923493
    [No Abstract]   [Full Text] [Related]  

  • 12. Interactions of gallamine and pancuronium with tubocurarine under morphine-nitrous oxide-oxygen anesthesia in man.
    Park WY; Balingit PE; Macnamara TE
    Anesth Analg; 1974; 53(5):723-9. PubMed ID: 4472154
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacokinetics of edrophonium and neostigmine when antagonizing d-tubocurarine neuromuscular blockade in man.
    Morris RB; Cronnelly R; Miller RD; Stanski DR; Fahey MR
    Anesthesiology; 1981 May; 54(5):399-401. PubMed ID: 7224209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmacokinetics of 14C-dimethyl-d-tubocurarine in patients with normal renal function and terminal chronic renal failure (incl. anephric patients)].
    Stoeckel H; Nold W
    Z Prakt Anasth Wiederbeleb Intensivther; 1972 Aug; 7(4):185-93. PubMed ID: 4664917
    [No Abstract]   [Full Text] [Related]  

  • 15. Safe reversal. 1. Atropine followed by neostigmine. An electrocardiographic study.
    Baraka A
    Br J Anaesth; 1968 Jan; 40(1):27-9. PubMed ID: 4866309
    [No Abstract]   [Full Text] [Related]  

  • 16. The effects of atropine and neostigmine on heart rate and rhythm. Recommendation for their use to reverse residual neuromuscular block.
    Rosner V; Kepes ER; Foldes FF
    Br J Anaesth; 1971 Nov; 43(11):1066-74. PubMed ID: 5131460
    [No Abstract]   [Full Text] [Related]  

  • 17. Renal failure and postoperative respiratory failure: recurarization?
    Miller RD; Cullen DJ
    Br J Anaesth; 1976 Mar; 48(3):253-6. PubMed ID: 1259893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Edrophonium: duration of action and atropine requirement in humans during halothane anesthesia.
    Cronnelly R; Morris RB; Miller RD
    Anesthesiology; 1982 Oct; 57(4):261-6. PubMed ID: 7125261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cost of anaesthetic agents.
    Hutchinson BR
    N Z Med J; 1967 May; 66(417):303-5. PubMed ID: 5230121
    [No Abstract]   [Full Text] [Related]  

  • 20. Anesthetic problems in uremic patients.
    Kacki J; Siedlecki J; Mayzner E; Zawadzki A
    Pol Med J; 1971; 10(2):333-9. PubMed ID: 4934227
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.